JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M408059200 on August 22, 2004

J. Biol. Chem., Vol. 279, Issue 44, 45766-45772, October 29, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/44/45766    most recent
M408059200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viñals, F.
Right arrow Articles by Ventura, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viñals, F.
Right arrow Articles by Ventura, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Myogenin Protein Stability Is Decreased by BMP-2 through a Mechanism Implicating Id1*

Francesc Viñals{ddagger}§ and Francesc Ventura{ddagger}

From the Unitat de Bioquímica, Departament de Ciències Fisiològiques II, Campus de Bellvitge, Universitat de Barcelona, E-08907 L'Hospitalet de Llobregat, Spain

Bone morphogenetic protein-2 (BMP-2) induces a switch in differentiation of mesenchymal cells from the myogenic to the osteogenic lineage. Here we describe that in C2C12 cells, BMP-2 decreases myogenin expression induced by des-(1,3) insulin-like growth factor-1 (des-(1,3)IGF-1) or ectopically expressed from a constitutive promoter, even in conditions where myogenin mRNA levels were unaffected. Addition of BMP-2 decreases myogenin protein half-life to 50%, whereas proteasome inhibitors abolish these effects. Forced expression of Id1, either by transient transfection or under the control of an inducible system, causes degradation of myogenin in the absence of BMP-2. In contrast, E47 overexpression blocks the inhibitory effect of BMP-2 on myogenin levels. Finally, expression of E47 in 293 cells stabilizes myogenin, an effect that is dependent on the heterodimerization mediated by their helix-loop-helix. Our findings indicate that induction of Id1 not only blocks transcriptional activity but also induces myogenin degradation by blocking formation of myogenin-E47 protein complexes.


Received for publication, July 16, 2004 , and in revised form, August 4, 2004.

* This work was supported by Grants BFI2001-2987 and BMC-2002-00737 from the Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica of the Ministerio de Ciencia y Tecnología (to F. Viñals and F. Ventura, respectively) and by a grant from the Generalitat de Catalunya (Distinció de la Generalitat a Joves Investigadors) to F. Ventura. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Both authors contributed equally to this work.

§ Supported by a contract from the Programa Ramón y Cajal of the Ministerio de Ciencia y Tecnología. To whom correspondence may be addressed: Unitat de Bioquímica, Departament de Ciències Fisiològiques II, Campus de Bellvitge, Universitat de Barcelona, C/Feixa Llarga s/n, L'Hospitalet de Llobregat, E-08907 L'Hospitalet de Llobregat, Spain. Tel.: 34-93-402-4281; Fax: 34-93-402-4268; E-mail: fvinals{at}ub.edu.

To whom correspondence may be addressed: Unitat de Bioquímica, Departament de Ciències Fisiològiques II, Campus de Bellvitge, Universitat de Barcelona, C/Feixa Llarga s/n, L'Hospitalet de Llobregat, E-08907 L'Hospitalet de Llobregat, Spain. Tel.: 34-93-402-4281; Fax: 34-93-402-4268; E-mail: fventura{at}ub.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Martinez-Moreno, A. Martinez-Ruiz, A. Alvarez-Barrientos, F. Gavilanes, S. Lamas, and I. Rodriguez-Crespo
Nitric Oxide Down-regulates Caveolin-3 Levels through the Interaction with Myogenin, Its Transcription Factor
J. Biol. Chem., August 10, 2007; 282(32): 23044 - 23054.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Scherner, S. K. Meurer, L. Tihaa, A. M. Gressner, and R. Weiskirchen
Endoglin Differentially Modulates Antagonistic Transforming Growth Factor-beta1 and BMP-7 Signaling
J. Biol. Chem., May 11, 2007; 282(19): 13934 - 13943.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Hayashi, K. Nimura, K. Kashiwagi, T. Harada, K. Takaoka, H. Kato, K. Tamai, and Y. Kaneda
Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling
J. Cell Sci., April 15, 2007; 120(8): 1350 - 1357.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.